Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Cancer. 2006 Jan 16;94(1):8-12.

The measurement and therapeutic implications of circulating tumour cells in breast cancer.

Author information

1
Department of Internal Medicine, Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. smerage@umich.edu

Abstract

Circulating tumours cells (CTCs) represent an important biologic link in the spread of breast cancer from primary to metastatic disease. CTCs are strong predictors of prognosis in patients with metastatic breast cancer. Research to date has focused on development of methods with adequate sensitivity and specificity to reproducibly identify these rare events. Future research will focus on the biologic phenotypes of these cells with goals to understand mechanisms of metastasis, to identify novel therapeutic targets, and to monitor response to therapy.

PMID:
16317435
PMCID:
PMC2361069
DOI:
10.1038/sj.bjc.6602871
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center